Escitalopram Oxalate

草酸艾司西酞普兰

Report date: 2022/08/16 20:00:19
NME

Base Information

Drug NameEscitalopram Oxalate
Drug Alias NameEscitalopramum草酸右依地普伦草酸依地普仑Sipralexa依他普仑 +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsSomatoform DisordersSchizophreniaBorderline Personality Disorder +[40] 
Global Approved IndicationsDepressive Disorder, MajorPanic DisorderAnxiety Disorders +[4] 
Approved Indications in ChinaPanic DisorderDepression
Original Approved Country/TerritoryUnited States
Original Approved Date2002/08/14
Country/TerritoryBelgiumCanadaUnited States +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical CenterYoshitomiUniversity Of Oxford +[12] 
Inactive CompaniesLundbeck Israel LtdLaboratório Catarinense SaChinese University Of Hong Kong (Cuhk) +[25] 
Active IndicationsDepressive Disorder, MajorPhobia, SocialPanic Disorder +[12] 
Inactive IndicationsSomatoform DisordersSchizophreniaBorderline Personality Disorder +[28] 

Other Information

ATC CodeN06AB10
Related LinksWikipediaDrugBankKEGG